Figure 1 | Scientific Reports

Figure 1

From: The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy

Figure 1

The association between the clinicopathological and genomic features of the study population. (a) The landscape of pathological feature observed in tissue samples and genomic alterations detected in baseline plasma samples of 31 gastric cancer patients. (b) Comparison of bTMB distribution between tumors with versus without MSI-H. (c) Relationship between bTMB and PD-L1 CPS. (d) Comparison of bTMB distribution between tumors with or without CNA. bTMB blood tumor mutation burden, CNA copy number alteration, dMMR mismatch repair-deficient, EBER-ISH Epstein–Barr virus (EBV)-encoded RNA in-situ hybridization, HER2 human epidermal growth factor receptor 2, IHC immunohistochemistry, ISH in-situ hybridization, MSI-H microsatellite instability-high, PD-L1 CPS programmed death ligand 1 combined positive score, PD progressive disease, PR partial response, SD stable disease.

Back to article page